Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Ivermectin in Rosacea
NCT02806414Phase 2Completed
- Sponsor
- University of California, San Diego
- Start
- Jul 2016
- Primary completion
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of ivermectin in rosacea, sponsored by University of California, San Diego. Primary endpoint: Relative Trypsin-like Enzyme Activity at 12 weeks. Started Jul 2016; status: completed.
02
Drugs
ivermectin
03
Conditions
rosacea
Beyond the preview
Go deeper on NCT02806414.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02806414.